OS Therapies Incorporated (OSTX)

US · Healthcare · Biotechnology

$1.63+5.16%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-10.4M

Profit YoY

-168.2%

EPS

$-0.27

EPS estimate

$-0.19

EPS came in at -0.27 against a street estimate of -0.19 — a miss of 42.1%.

Market cap

$69.2M

Forward P/E

1.7

P/B

13.65

Book value

$-0.28

EPS (TTM)

$-1.07

52-week high

$2.57

52-week low

$1.15

50-day MA

$1.72

200-day MA

$1.61

Analysts rate OS Therapies Incorporated a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $8.92.

Insiders

21.65%

Institutions

6.32%

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for OS Therapies Incorporated — free to start.

Data updated 2026-08-05.